Gene Therapy in Recurrent Glioma Shows Promise in Early Trial – Cancer Network
|
Gene Therapy in Recurrent Glioma Shows Promise in Early Trial
Cancer Network More than 25% of patients with recurrent, high-grade glioma treated with a gene therapy combination were alive more than 3 years after treatment, according to data from a subset of patients in a phase I clinical trial presented at the AACR-NCI-EORTC … |
